Search Results 71-80 of 21235 for anti-TNF drugs

1. Mayo Clinic researchers to present study findings at American College of Gastroenterologists Annual Scientific Meeting

   "When we examined the risk for preeclampsia in those on anti-TNF therapy ... "We theorize that exposure to anti-TNF agents is a marker of more severe ...

2. Immunosuppressive Drugs Clinical Trials - Mayo Clinic Research

   The purpose of this study is to compare the efficacy of treatment with ustekinumab or adalimumab in biologic naive participants with moderately-to-severely ...

3. Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 - Mayo Clinic

   ... treatment with modifying antirheumatic drugs (DMARDs) or anti-TNF alpha agents. Participation eligibility. Participant eligibility includes age, gender, type ...

4. Breast cancer chemoprevention: Drugs that reduce risk - Mayo Clinic

   Preventive medications can reduce breast cancer risk. Learn about how these drugs work, who should consider taking them, plus their side effects and health ...

5. Microscopic colitis - Diagnosis and treatment - Mayo Clinic

   Biologic medicines, such as infliximab (Remicade), adalimumab (Humira) or vedolizumab (Entyvio). These can reduce swelling and irritation in the colon. Surgery.

6. COVID-19 drugs: Are there any that work? - Mayo Clinic

   The U.S. Food and Drug Administration (FDA) authorized this treatment to prevent COVID-19 in some people with weakened immune systems. Medicines to treat COVID- ...

7. Infliximab (Intravenous Route) Description and Brand Names - Mayo Clinic

   Infliximab injection is used alone or together with other medicines (eg, methotrexate) to reduce the symptoms and prevent the progression of ...

8. A Study of Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... etanercept for the treatment of patients with psoriatic arthritis (PsA).

9. A Study to Evaluate both the Efficacy and Safety Profile of CP-690,550 in Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   ... anti-TNF-alpha therapy. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

10. A Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... A Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients with ...